NCT02229253View on ClinicalTrials.gov

Real-life Data of Cardiovascular Events Occuring During Degarelix Therapy for Prostate Cancer

CompletedOBSERVATIONAL
Enrollment

112

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

October 4, 2017

Study Completion Date

October 4, 2017

Conditions
Advanced Hormone Sensitive Prostate Cancer
Interventions
DRUG

degarelix

Trial Locations (1)

Unknown

Groene Hart Ziekenhuis (there may be other sites in this country), Gouda

Sponsors
All Listed Sponsors
lead

Ferring Pharmaceuticals

INDUSTRY